InvestorsObserver is giving Achieve Life Sciences Inc (ACHV) an Analyst Rating Rank of 79, meaning ACHV is ranked higher by analysts than 79% of stocks. The average projection by analysts for ACHV is $45 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Achieve Life Sciences Inc Stock Today?
Achieve Life Sciences Inc (ACHV) stock has risen 7.26% while the S&P 500 is down -0.45% as of 3:06 PM on Friday, Jan 15. ACHV is up $0.66 from the previous closing price of $9.09 on volume of 296,404 shares. Over the past year the S&P 500 has risen 13.92% while ACHV is down -18.68%. ACHV lost -$8.76 per share the over the last 12 months.
Click Here to get the full report on Achieve Life Sciences Inc (ACHV) Stock.